Adding Tirzepatide vs Prandial Insulin to Basal Insulin, Beta-Blockers in Septic Shock, USPSTF on Oral Health Screening, and more
JAMA Editors' Summary
Introduction
This chapter reviews a research article comparing the efficacy and safety of Chrysepatide and Insulinless Pro as adjunctive therapies to basal insulin in patients with Type 2 diabetes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
